NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

You are a broken record. If you don't buy the rGBM arm, then go read the 2018 JTM blinded paper or the blended arm where the results excelled the SOCs as well. OS is the Gold Standard. PFS is for those who can't run the trial too long to collect OS data; plus PFS doesn't work well in immunotherapy but it is something every trialist wants to see on top of collecting OS data these days. LL et al are trying to find a way to stop the immunotherapy trial early on using some PFS techniques and I think they are testing their method in their combo study with a PFS measure and OS as well that you are quoting. See the listing and stop fuding spreading false image that they are only measuring PFS. They are also measuring OS as the trial started in 2020 and projected to go till 2025. Stop FUDs.

https://clinicaltrials.gov/ct2/show/NCT04201873